NCT03028077

Effects of GS-3K8 and GINst15 on Acute Respiratory Illness

The Efficacy and Safety of GS-3K8 and GINst15 on Acute Respiratory Illness in Healthy Subjects

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 45 (actual)
• Sponsor: Chonbuk National University Hospital · Academic / Other
• Sex: All
• Age: 39 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study was conducted to investigate the effects of daily supplementation of GS-3K8 or GINst15 on acute respiratory illness (ARI) in healthy subjects.

Detailed description

This study was a 8 weeks, randomized, double-blind, placebo-controlled trial. Forty five subjects were randomly divided into GS-3K8 (Ultrafiltered red ginseng extract) or GINst15 (Hydrolyzed ginseng extract) or placebo group. The primary clinical outcome measure was the incidence of ARI. The secondary clinical outcome measure was the development and duration of ARI symptoms.

Conditions

• Acute Respiratory Infection

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	GS-3K8	GS-3K8 (ultrafiltered red ginseng extract) 1 g/day
DIETARY_SUPPLEMENT	GINst15	GINst15 (hydrolyzed ginseng extract) 1 g/day
DIETARY_SUPPLEMENT	Placebo	Placebo 1 g/day

Timeline

• Start date: 2014-10-01
• Primary completion: 2015-03-01
• Completion: 2015-03-01
• First posted: 2017-01-23
• Last updated: 2017-01-23

Locations

1 site across 1 country: South Korea